CDC's new style

Executive leadership team formed to apply business model to disease agency's operations

Written byEmma Hitt
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

After nearly 7 months as director of the Atlanta-based Centers for Disease Control and Prevention (CDC), Julie Gerberding has announced the formation of a new executive leadership team modeled on a corporate approach. She chose a business model to manage CDC and its sister agency, the Agency for Toxic Substances and Disease Registry (ATSDR), "after consulting with corporate executives and seeing how the model could improve the agency's effectiveness, accountability and impact," according to a statement accompanying the announcement.

The team, which is already in place, is made up of five people, all of whom have experience working with the CDC or in public health. They are David Fleming, deputy director for public health science; William H. Gimson, chief operating officer; Ed Thompson, deputy director for public health services; Kathy Cahill, senior advisor for strategy and innovation; and Verla Neslund, acting chief of staff.

According to Fleming, Gerberding is trying ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery